Feedback

South Korea stops vaccination with AstraZeneca

Source : 112 Ukraine

Meanwhile, the country approved Johnson & Johnson vaccine
18:20, 7 April 2021

Open source

South Korea states it temporarily stops vaccination against coronavirus with AstraZeneca drug of people younger than 60. The country approved Johnson & Johnson vaccine, as Reuters reported.

“South Korea will temporarily suspend providing AstraZeneca’s COVID-19 vaccine to people below 60 amid a European review,” the message said.

It is mentioned that the EMA should announce the results of the study whether or not some cases of blood clotting of adults are tied with the AstraZeneca vaccine.

Related: Thrombotic scandal, decline in efficiency, renaming: How's it going with AstraZeneca?

Meanwhile, South Korea’s food and drug safety ministry stated that it provided the final agreement for the Johnson & Johnson vaccine after the group of experts defined that a single shot was safe and effective.

On April 6, the EMA representative confirmed there is a connection between the AstraZeneca vaccine against coronavirus and the development of blood clots in the patients' bodies.

The first messages about side effects after vaccination with AstraZeneca (Vaxzevria) appeared in early March. Austria was the first to state it suspends the vaccination with the use of this drug. Later, more than 20 countries did the same.

Related: U.S. factory shuts down production of AstraZeneca vaccine

Currently, the lethal cases after the AstraZeneca drug were reported by the UK, Norway, Georgia, Germany and other countries.

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more